VCYT Jul 2024 22.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:04AM EDT. Market open.
Loading interactive chart…
- Zacks
3 Medical Instruments Picks to Navigate Industry Challenges
Deteriorating geopolitical situation and supply bottlenecks mar the prospects of the Zacks Medical Instruments industry. Yet, HOLX, MASI and VCYT are worth buying based on strategic developments and fundamentals.
- Zacks
Zacks.com featured highlights Veracyte, Steelcase and Applied Industrial
Veracyte, Steelcase and Applied Industrial have been highlighted in this Screen of The Week article.
- Zacks
Wall Street Analysts See a 37.09% Upside in Veracyte (VCYT): Can the Stock Really Move This High?
The mean of analysts' price targets for Veracyte (VCYT) points to a 37.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
© 2024 Yahoo. All rights reserved.